National Path Lab (NPL) stands at the forefront of healthcare, dedicated to providing high-quality, patient-centered diagnostic services across a broad spectrum of specialties. Our commitment to excellence drives us to continuously enhance our offerings and ensure the well-being of our patients and communities.
Cytogenetics
We offer advanced cytogenetic testing to analyze chromosomes and detect genetic abnormalities that may lead to inherited disorders, cancers, and other conditions.
At National Path Lab (NPL), we offer advanced newborn screening to ensure early detection of serious yet treatable genetic, metabolic, and endocrine disorders.
At National Path Lab (NPL), we offer advanced Immunohistochemistry (IHC) testing with over 80 markers to provide precise and accurate diagnosis of various cancers and diseases.
We offer advanced Immunofluorescence (IF) testing used for diagnosing vesiculobullous (blistering) diseases of skin, kidney diseases and autoimmune diseases respectively.
We utilize advanced microarray-based multiplex testing for the rapid and comprehensive detection of respiratory, gastrointestinal, and central nervous system (CNS) infections.